Prof. Rob Timmermans is a Professor of Theoretical Physics and Vice-Dean for Education at the University of Groningen (UG). He is affiliated with the Faculty of Science and Engineering and the Precision Frontier — Van Swinderen Institute for Particle Physics and Gravity. His research focuses on theoretical particle physics, quantum mechanics, and precision measurements, particularly in electric dipole moment (EDM) searches using molecules like BaF. His work includes developing methods for molecular beam manipulation, phase-space analysis, and symmetry violation studies. He has contributed to collaborations such as NL-eEDM, advancing techniques for EDM detection and precision physics. Prof. Timmermans has received nominations for teaching awards, reflecting his commitment to education. Research highlights include studies on nucleon decay, antinucleon-nucleon interactions, and chiral effective field theory. His lab activities involve collaborations on laser-cooled molecules and trapping techniques. Prof. Timmermans’ articles often address fundamental physics questions, such as Lorentz violation in beta decay and parity violation in molecular systems. Awards: Nominated for Faculty Teaching Award 2014, Teacher of the Year 2014-15. Grants/Advising: Leads projects on EDM searches and particle physics, with active roles in international collaborations. Labs/Teams: Van Swinderen Institute, Precision Frontier group.
Dr. James McDonald serves as a Lecturer and Research Fellow at the University of New South Wales (UNSW) within the School of Civil and Environmental Engineering's Water Research Centre (WRC). His work at the Vallentine Annexe (H22), Room 102, Kensington Campus focuses on advancing water treatment technologies and understanding contaminant behavior in water systems. His position bridges academic instruction with cutting-edge research in environmental engineering. McDonald's research spans multiple critical areas in water science and engineering, with particular emphasis on trace organic contaminants, membrane technologies, and advanced water treatment processes. His work investigates the fate and removal of pharmaceuticals, personal care products, and industrial chemicals in various water treatment systems. He has made significant contributions to understanding disinfection by-product formation, chiral inversion of pharmaceuticals, and the development of novel membrane technologies for improved water purification. His research combines experimental approaches with computational modeling to address complex water quality challenges. Analysis of McDonald's recent publications reveals a strong focus on emerging contaminants, particularly PFAS compounds and chiral pharmaceuticals, and their behavior in water treatment systems. His work demonstrates expertise in both conventional and advanced water treatment technologies, with increasing emphasis on sustainable approaches including green infrastructure and novel membrane processes. The interdisciplinary nature of his research connects environmental engineering, chemistry, microbiology, and materials science to address contemporary water quality challenges. McDonald actively collaborates with researchers across multiple institutions and has contributed to numerous significant studies on water quality and treatment. His work supports the development of more effective water recycling systems and safer drinking water supplies. While specific grant information isn't detailed in the available text, his extensive publication record suggests sustained research funding in water treatment technologies and contaminant fate studies. As part of UNSW's Water Research Centre, McDonald contributes to one of Australia's leading water research facilities. The WRC provides a collaborative environment for addressing complex water challenges through interdisciplinary research that integrates engineering, chemistry, and environmental science perspectives.
Jon Simon is the Joan Reinhart Professor and Professor of Applied Physics at Stanford University . He leads the Simon Lab , which explores the convergence of condensed matter physics , quantum optics , and quantum information science , focusing on creating synthetic materials from light and investigating topological and strongly correlated quantum systems. His research spans constructing photonic materials in quantum circuits, studying small quantum systems with strong correlations, and applying Hamiltonian engineering to realize exotic states of matter. The lab has achieved milestones like the first Mott insulator of photons and topologically insulating circuits . Collaborative projects with the Schuster Lab leverage superconducting quantum circuits for synthetic matter studies. Jon's students include Adam Shaw (PhD, now at Stony Brook) Lavanya Taneja (PhD, now at Atom Computing) Ruichao Ma (Postdoc, now faculty at Purdue) among others. The lab's recent publications focus on cavity arrays, hybrid quantum systems, and topological photonics. Research is supported by grants and affiliations with Stanford's Department of Applied Physics and interdisciplinary institutes.
Roles & Affiliations: Ikhlas Khan serves as Director of the National Center for Natural Products Research (NCNPR), Distinguished Professor, and Research Professor of Pharmacognosy at the University of Mississippi's School of Pharmacy. He also leads the FDA Program and coordinates natural products research across multiple initiatives, including the Sino-US TCM Research Center and the Center for Research of Indian Systems of Medicine (CRISM). Education: B.Sc. Chemistry (1980) - Aligarh Muslim University, India M.Sc. Organic Chemistry (1982) - Aligarh Muslim University, India Ph.D. Pharmacy (1987) - Ludwig-Maximilians-Universität, Munich Postdoctoral Studies - Swiss Federal Institute of Technology (ETH), Zurich Research Focus: Dr. Khan specializes in natural products research with emphasis on: Phytomedicine: Standardization of herbal products via analytical fingerprinting, pesticide/herbicide residue analysis, and bioanalytical quality control. Drug Discovery: Isolation of bioactive natural products, development of analytical methods for phytochemical characterization, and chiral separation techniques. Metabolism Studies: Role of metabolism in drug/natural product activity, particularly in aminoquinoline antimalarials. His work bridges academia, industry, and regulatory bodies, shaping policies for botanical supplements. Key Contributions: Over 850 peer-reviewed publications and leadership in high-impact projects like the FDA Center of Excellence. His lab pioneered methods to combat herbal product adulteration and safety issues. Awards & Recognition: UM Distinguished Professor Award (2018) Wiley Award (AOAC International, 2018) Qihuang International Prize (2017) Honoris Causa Doctorate (University of Hamdard, 2012) Labs & Collaborations: Directs the NCNPR, a global leader in natural products research, and collaborates with institutions worldwide. His team develops technologies for herbal product authentication and drug metabolism studies.
Prof. Dr. Malte Oppermann is a full Professor at the University of Basel , leading the Ultrafast Chiral Dynamics Laboratory within the Department of Chemistry. His group specializes in developing cutting-edge time-resolved spectroscopic techniques to probe molecular transformations on femtosecond to microsecond timescales, focusing on chirality and structural dynamics in complex systems. Research Focus: Ultrafast Chiral Spectroscopy : Using circularly polarized laser pulses to resolve structural changes in chiral systems. Molecular Motors & Protein Dynamics : Capturing conformational changes in synthetic motors and proteins in native environments. Photoactive Materials : Investigating light-energy conversion mechanisms in chiral photochemical systems. His research bridges physics and chemistry, employing state-of-the-art laser technology and collaborating internationally across synthesis, spectroscopy, and theory. Publications & Impact: Prof. Oppermann’s work (2011–2025) spans ultrafast spectroscopy , chiral dynamics , nanomaterials , and biomolecular photophysics . Key themes include spin-crossover dynamics, DNA photodamage, and plasmonic nanoparticles, with techniques like transient X-ray absorption and deep-UV circular dichroism. Team & Opportunities: The group actively recruits MSc/PhD students and postdocs in physics, chemistry, and materials science. Interested candidates are encouraged to contact Prof. Oppermann directly.
Vikramaditya G. Yadav is an Associate Professor at the University of British Columbia (UBC) in the Department of Chemical and Biological Engineering, Faculty of Applied Science. He directs the Master of Engineering Leadership (MEL) Program in Sustainable Process Engineering and leads the BioFoundry research group. Education: B.A.Sc., University of Waterloo (2007) Ph.D., Massachusetts Institute of Technology (2013) Postdoctoral Associate, Harvard University (2014) His research spans sustainable chemical manufacturing, metabolic engineering, and biotechnology. Key areas include: Designing biosynthetic enzymes for biomass valorization Developing bioremediation strategies for industrial water quality Creating innovative drug delivery systems and tissue engineering solutions Advancing synthetic biology for pharmaceutical and bioenergy applications His recent work focuses on ocular drug delivery, cannabinoid biosynthesis in E. coli, lignin-based nanoparticles for cancer therapy, and computational analysis of plant secondary metabolites. Collaborations with start-ups, industry, and medical labs drive innovation in Canada's bioeconomy. Professional Leadership: Chair, Biotechnology Division of the Chemical Institute of Canada Associate Editor, The Canadian Journal of Chemical Engineering He is affiliated with UBC's BioProducts Institute and contributes to project-based learning pedagogy.
Weiping Tang is a Professor of Pharmaceutical Sciences and Chemistry at the University of Wisconsin-Madison, holding the Janis Apinis Professorship in the School of Pharmacy and the Vilas Distinguished Achievement Professorship. He also serves as Director of the Medicinal Chemistry Center at the School of Pharmacy and maintains a faculty appointment with the Department of Chemistry in the College of Letters and Science. Janis Apinis Professor of Pharmaceutical Sciences Vilas Distinguished Achievement Professor Director of Medicinal Chemistry Center Faculty Appointment with Department of Chemistry Dr. Tang received his B.S. in Chemistry from Peking University in 1997, M.S. in Chemistry from New York University in 1999, Ph.D. in Organic Chemistry from Stanford University in 2005, and completed a postdoctoral fellowship in Medicinal Chemistry, Chemical Biology and Drug Discovery at Harvard University in 2007. Dr. Tang's research program focuses on drug discovery for cancer, infectious diseases, and neurodegenerative disorders through three interconnected areas: Organic Synthesis (advancing glycoscience through novel carbohydrate synthesis technologies), Medicinal Chemistry (developing small molecules that selectively remove disease-associated proteins), and Chemical Biology (dissecting biological pathways using novel small molecule probes). His group operates as an interdisciplinary team where chemists and biologists collaborate closely on drug discovery projects, with particular emphasis on developing novel degraders for disease-causing proteins. Analysis of Dr. Tang's publication record reveals a significant shift toward targeted protein degradation technologies, particularly PROTACs and molecular glues, while maintaining strong foundations in carbohydrate chemistry. His most impactful recent work includes developing degraders for extracellular and membrane proteins (previously considered 'undruggable'), creating rapid synthesis platforms like Rapid-TAC and Rapid-Glue, and advancing understanding of ternary complex formation for novel PROTAC design. His research spans both chemical methodology development and therapeutic applications across multiple disease areas. Vilas Distinguished Achievement Professorship Janis Apinis Professorship Numerous high-impact publications in leading chemistry and pharmacology journals Editor's pick and hot paper designations for significant contributions Dr. Tang mentors a diverse team of graduate students, postdoctoral fellows, and staff scientists with expertise spanning synthetic chemistry, medicinal chemistry, carbohydrate chemistry, computational chemistry, biochemistry, and cell biology. His group has developed innovative platforms for the rapid synthesis of protein degraders and has made significant contributions to understanding the mechanisms of action for these novel therapeutics. Current research includes developing selective degraders for cancer targets like RIPK1, BRD4, and CARM1, as well as advancing delivery systems for clinical translation. The Tang Research Group maintains state-of-the-art facilities within the School of Pharmacy at UW-Madison, equipped for comprehensive chemical synthesis, compound characterization, and biological evaluation. The group actively collaborates with researchers across campus and with industry partners to advance discoveries toward clinical applications, with particular focus on cancer therapeutics and protein degradation technologies.
Dr. Muhammad Gulzari is an Assistant Professor at the School of Civil Engineering, University College Dublin (UCD). Previously, he held positions as Lecturer/Assistant Professor at the University of Galway (2023–2024), Adjunct Assistant Professor at Trinity College Dublin (2022–2023), and a Research Fellow at Trinity College Dublin (2021–2023). He earned his Ph.D. in Civil Structural Engineering from City University of Hong Kong (2021) and a B.Sc. in Civil Engineering from the University of Engineering and Technology Lahore (2017). Education: Bachelor of Engineering, Civil Engineering, University of Engineering and Technology Lahore Ph.D., Civil Structural Engineering, City University of Hong Kong Research Interests: His work focuses on structured materials and dynamics, including finite element modeling, phononic crystals, acoustic and mechanical metamaterials, vibration and noise control, and applications in structural health monitoring. He leads the Structured Materials and Dynamics Lab at UCD, exploring nonlinear and nonreciprocal metamaterials. Teaching and Awards: He has taught courses in Fluid Mechanics, Thermodynamics, and Combustion Engineering. Notable recognitions include the Seal of Excellence Award from the EU-Horizon MSCA Postdoctoral Fellowship (2021) and nominations for teaching excellence awards at Trinity College Dublin and University of Galway. Grants: TimberFlow: Enhancing Efficiency in Mass Timber Construction (Enterprise Ireland, 2025) Indoor Acoustic Quality via Acoustic Metamaterials (Enterprise Ireland, 2025) RUBBERPAVE: ELT Integration in Pavement Construction (Enterprise Ireland, 2024–2026) Deep Learning for Metamaterial Design (Irish Research Council, 2021–2023) Labs and Collaborations: His research group collaborates with industry partners like Amplitude Acoustics and G-frame Structures Ltd. Key projects include developing metamaterials for noise/vibration control and sustainable construction materials.
Catherine Pinel is a Research Director (DR2) at the Institute for Research on Catalysis and Environment of Lyon (IRCELYON, UMR 5256), a joint research unit of the French National Center for Scientific Research (CNRS) and Claude Bernard University Lyon 1. She has held this senior research position since October 2008, following progression from CR1 (1998-2008) and CR2 (1994-1998) roles at the same institution. Her academic journey includes postdoctoral research at Cambridge University (1992-1993) under Professor S.V. Ley and with Professor M. Lemaire (1993-1994). Her educational foundation includes: Diplôme Universitaire de Technologie in Chemistry from Paris XI University (1986) Engineering Degree from École Nationale Supérieure de Chimie de Paris (1989) Advanced Studies Diploma in Organic Chemistry from Paris VI University (1989) PhD in Organic Chemistry from Paris VI University (1992) on chiral ruthenium complexes and enantioselective reductions Habilitation à diriger des recherches from Lyon I University (1999) on catalysis and fine chemistry Dr. Pinel's research pioneers sustainable catalytic processes with emphasis on biomass valorization, green chemistry, and heterogeneous catalysis. Her work bridges fundamental catalyst design with industrial applications, particularly in hydrogenation, oxidation, and biorefinery processes. Current focus areas include catalytic conversion of biomass-derived platform molecules (glucose, succinic acid, polyols), development of bimetallic catalysts, and valorization of hemicellulose streams. Her approach integrates advanced catalyst characterization with reaction engineering to create environmentally benign chemical transformations. Analysis of her recent publication trajectory (2019-2025) reveals evolving expertise from fundamental organometallic chemistry toward applied sustainable catalysis. Key trends include increasing focus on biomass-derived feedstocks (glucose, succinic acid, polyols), development of metal-carbide/nitride catalysts, and optimization of aqueous-phase reactions for industrial biorefineries. Her work demonstrates strong interdisciplinary collaboration across catalysis, materials science, and green chemistry, with growing emphasis on circular economy principles and renewable chemical production. No scientific awards were explicitly mentioned in the source materials. Dr. Pinel actively contributes to academic training through graduate instruction at University of Lyon (Master 2 'Catalysis and Physical Chemistry' since 2007) and University of Savoie (M2 courses in New Catalysts in Organic Chemistry since 1999 and Coordination Chemistry since 2012). While specific grant details aren't provided, her extensive publication record across high-impact journals indicates sustained research funding. She maintains collaborative networks within IRCELYON and internationally, particularly in biomass conversion and catalyst characterization. As a core researcher at IRCELYON (celebrating 60 years of catalysis research in 2021), she operates within a world-class facility housing specialized equipment for catalyst synthesis, characterization (including in situ techniques), and testing. Her work aligns with the institute's focus on sustainable catalysis for energy transition, air/water depollution, and biomass valorization, contributing to France's strategic research priorities in green chemistry.
Ulf Hanefeld is a Full Professor and Section Leader in the Department of Biotechnology at the Faculty of Applied Sciences , Delft University of Technology (TU Delft) , where he leads the Biocatalysis research section. His work integrates chemistry and biology to develop sustainable synthetic methodologies using enzymes. PhD from Georg-August-Universität zu Göttingen (1993) Postdoctoral experience at Imperial College London, University of Cambridge, and TU Delft Recipient of a Royal Netherlands Academy of Arts and Sciences (KNAW) fellowship His research interests center on biocatalysis , particularly enzymes that enable difficult chemical transformations such as C–C bond formation , enantioselective hydration , and ozonolysis . He focuses on enzyme discovery, engineering, immobilization, and application in flow chemistry to achieve sustainable and efficient synthesis. His work spans from fundamental enzyme mechanism studies to industrial applications in green chemistry . The publication trends reveal a consistent focus on enzyme immobilization , flow reactor systems , and chemo-enzymatic cascades . His recent work emphasizes the use of hydroxynitrile lyases , aldolases , and methyltransferases for the synthesis of chiral intermediates under environmentally benign conditions. The integration of biocatalysis with continuous manufacturing highlights a strong commitment to industrial applicability and process sustainability. Scientific contributions and recognition : Active contributor to high-impact journals in chemistry and biotechnology Coordinated research in the CassaFLOW project (international academic-industrial collaboration) Author of influential reviews, e.g., in Chemical Society Reviews (2022) Teaching and supervision : He teaches Catalysis (Bachelor) and Advanced Biocatalysis (Master), and supervises numerous Master’s theses (MEP) and Bachelor’s projects (BEP) . Students in his group are actively involved in research and often become co-authors on scientific papers. Projects center on green chemistry, enzyme engineering, and spectroscopic analysis of biochemical systems. Laboratory and research environment : The Ulf Hanefeld Group operates within the Biocatalysis section, a multidisciplinary environment fostering collaboration on enzyme discovery, immobilization, and cascade reactions. The group emphasizes practical innovation, with strong links to industry and international research networks.
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Virgil Percec is the P. Roy Vagelos Professor of Chemistry at the University of Pennsylvania, affiliated with the School of Arts & Sciences and the Department of Chemistry. His research focuses on organic, supramolecular, and macromolecular chemistry, with an emphasis on self-assembly, drug delivery systems, and biomimetic nanosystems. He holds a B.S. and Ph.D. from institutions in Jassy, Romania, and conducted postdoctoral research at the University of Freiburg and the University of Akron. Research Interests: Percec’s work integrates synthetic methods, catalysis, and structural biology to design functional nanosystems. Key areas include hierarchical folding, supramolecular chirality, and synthetic mimics of biological membranes. His lab explores mRNA delivery systems using Janus dendrimers and studies self-organized structures like helical columns and quasicrystals. Recent Articles: His recent publications highlight advancements in mRNA delivery mechanisms, supramolecular architectures, and polymer synthesis innovations. The group’s work often involves interdisciplinary collaborations, bridging chemistry, materials science, and bioengineering. Awards: Percec was elected a Foreign Member of the Academia Europaea (2020) and delivered the inaugural ACS Kavli Lecture (2011). His lab has trained numerous students and postdocs, including Juncheng Lu (Master’s Capstone Award recipient) and Devendra Maurya (SET-LRP research). Labs & Teams: The Percec Research Laboratory at Penn develops cutting-edge biomaterials and supramolecular systems. The group collaborates globally, with projects funded by grants exploring nanotechnology and drug delivery.
Anna Delin is a Full Professor at KTH Royal Institute of Technology since 2011, leading research on magnetic and quantum phenomena in materials. She heads the WISE research school (wise-materials.org) and served as Deputy Head of the School of Engineering Sciences (SCI) from 2018–2022. Her expertise spans condensed matter physics, with a focus on nanomagnetism, skyrmions, spin-lattice couplings, and topological materials. Education: PhD in Condensed Matter Physics from Uppsala University (1998). Key awards include Naturvetarpriset (1998), Royal Swedish Academy of Sciences Research Fellowship (2007), Thuréus Prize (2018), and Edlundska Prize (2024). She has held visiting roles at ICTP, Los Alamos National Lab, and the Fritz Haber Institute. Research interests include magnetic skyrmions, magnonics, spintronics, and ultrafast demagnetization. Recent publications focus on spin-lattice dynamics, topological materials, and quantum analogs of classical magnetic models. Her work bridges theory and experiment, with contributions to tools like SpinView for computational magnetism analysis. Teaching includes roles as examiner for the Degree Project in Applied Physics and teacher for Sustainable Development in Engineering Physics. She actively participates in materials design initiatives and semantic data processing for big research data. Lab affiliations include her own research group at KTH and collaborations through WISE. Current projects explore skyrmion stabilization, magnon entanglement, and quantum spin systems, with implications for next-generation spintronic devices.
Harri Lähdesmäki is an Associate Professor (tenured) at the Department of Computer Science, Aalto University, where he leads the Computational Systems Biology research group. His work focuses on probabilistic machine learning and deep generative models with applications in biomedicine and molecular biology. Key Research Interests: Probabilistic machine learning, deep generative models, computational biology, bioinformatics, longitudinal data modeling Contact: harri.lahdesmaki@aalto.fi | Konemiehentie 2, 02150 Espoo, Finland His recent publications highlight advancements in: Gaussian process priors for scalable deep generative models Single-cell analysis of immune repertoires in leukemia and diabetes Probabilistic deconvolution methods for RNA-seq data Epigenetic analysis using hidden Markov and mixed models Transformer-based survival prediction and missing data handling Harri’s work integrates mechanistic modeling with Bayesian inference, particularly applied to immunology, cancer biology, and early disease prediction.
Stéphane BAUDRON is a CNRS Research Director at the Laboratory for the Synthesis and Functions of Molecular Architectures within the Faculty of Chemistry at the University of Strasbourg. His research spans multiple areas of molecular materials chemistry, with particular expertise in coordination polymers, metal-organic frameworks, and supramolecular architectures. Dr. BAUDRON's educational background includes undergraduate studies at the National School of Chemistry of Paris (1998), a Ph.D. from the University of Angers under Dr. Patrick Batail (2002), and postdoctoral research at the University of California Berkeley with Prof. Jeffrey R. Long (2002-2004). He joined CNRS as a researcher in 2004, received his Habilitation from the University of Strasbourg in 2009, and was promoted to CNRS Research Director in 2019. His primary research interests focus on dipyrrin-based complexes and assemblies for luminescent materials and heterometallic frameworks, conducting coordination polymers using redox-active ligands, and the application of deep eutectic solvents for sustainable synthesis of porous materials. His work bridges fundamental coordination chemistry with practical applications in materials science. Analysis of his recent publications reveals a strong trend toward green chemistry approaches for synthesizing metal-organic frameworks, with increasing focus on deep eutectic solvents as environmentally friendly alternatives to traditional solvents. His research spans both fundamental coordination chemistry and applied materials science, with particular emphasis on structure-property relationships in crystalline materials. Lavoisier fellowship (French Ministry of Foreign Affairs) JSPS short-term invitation fellowship at Kyoto University USIAS fellowship ANR DEEPCatCOF project (Principal Investigator) Dr. BAUDRON has successfully mentored numerous graduate students who have gone on to careers in both industry and academia, including positions at Michelin, BASF, and various universities. His current research is supported by multiple grants, including the ANR DEEPCatCOF project focused on deep eutectic solvents for catalytic metal-organic frameworks. His laboratory maintains strong international collaborations with research groups in Japan, Portugal, and other European institutions. Based at the University of Strasbourg's Institute Le Bel, Dr. BAUDRON leads a research team within the Laboratory for the Synthesis and Functions of Molecular Architectures, which is part of the larger Faculty of Chemistry structure. His group actively collaborates with other laboratories within the chemistry faculty, particularly those working on spectroscopy, mass spectrometry, and molecular modeling.
